| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 124.57B | 129.02B | 123.52B | 126.44B | 120.65B | 118.05B |
| Gross Profit | 33.71B | 35.69B | 33.37B | 31.29B | 28.67B | 31.23B |
| EBITDA | 12.58B | 13.88B | 13.11B | 12.12B | 10.06B | 13.27B |
| Net Income | 7.04B | 8.41B | 7.57B | 6.72B | 4.08B | 6.22B |
Balance Sheet | ||||||
| Total Assets | 146.74B | 156.54B | 137.09B | 143.34B | 132.00B | 130.33B |
| Cash, Cash Equivalents and Short-Term Investments | 24.59B | 30.31B | 19.47B | 22.08B | 20.79B | 25.25B |
| Total Debt | 23.75B | 23.12B | 20.30B | 28.09B | 31.72B | 33.69B |
| Total Liabilities | 62.04B | 62.29B | 56.82B | 70.64B | 69.07B | 70.42B |
| Stockholders Equity | 84.70B | 94.25B | 80.27B | 72.69B | 62.92B | 59.90B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.52B | 5.62B | 2.81B | -4.34B | 3.09B |
| Operating Cash Flow | 0.00 | 9.33B | 8.50B | 4.62B | 641.00M | 8.17B |
| Investing Cash Flow | 0.00 | -5.29B | -2.30B | 843.00M | -3.05B | -5.74B |
| Financing Cash Flow | 0.00 | 1.64B | -8.76B | -4.42B | -3.94B | -2.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥4.74T | 23.62 | 9.46% | 1.32% | 3.47% | 99.65% | |
71 Outperform | ¥1.39T | 21.75 | 11.19% | 1.46% | 5.16% | 1.57% | |
71 Outperform | ¥575.76B | 28.74 | 9.28% | 1.30% | 5.86% | -17.47% | |
66 Neutral | ¥130.99B | 24.96 | ― | 1.08% | 4.45% | 11.13% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥341.86B | 38.25 | 4.15% | 1.66% | 0.49% | -39.52% | |
53 Neutral | ¥803.12B | 19.10 | 9.77% | 2.41% | 1.49% | -14.54% |